- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 55/22 - Acides tricarboxyliques
Détention brevets de la classe C07C 55/22
Brevets de cette classe: 52
Historique des publications depuis 10 ans
|
2
|
4
|
6
|
3
|
5
|
4
|
2
|
3
|
6
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Novartis AG | 10886 |
5 |
| Bristol-myers Squibb Company | 4879 |
4 |
| Ventana Medical Systems, Inc. | 1021 |
3 |
| Ascend Performance Materials Operations LLC | 272 |
2 |
| Furman University | 39 |
2 |
| The Lubrizol Corporation | 1283 |
2 |
| The Michigan Biotechnology Institute | 17 |
2 |
| PfP Technology, LLC. | 7 |
2 |
| Purac Biochem B.V. | 482 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3137 |
2 |
| LG Chem, Ltd. | 17594 |
1 |
| Toyota Motor Corporation | 31764 |
1 |
| Janssen Pharmaceutica N.V. | 3396 |
1 |
| Amgen Inc. | 4071 |
1 |
| Saudi Basic Industries Corporation | 572 |
1 |
| Chevron U.S.A. Inc. | 3947 |
1 |
| Agency for Science, Technology and Research | 3605 |
1 |
| Vertex Pharmaceuticals Incorporated | 1595 |
1 |
| Northwestern University | 3374 |
1 |
| CTI Biopharma Corp. | 35 |
1 |
| Autres propriétaires | 16 |